Jump to navigation
MuyldermansGroup
Muyldermans, S., Vrijsen B., Decramer M., Belge C., Testelmans D., and Buyse B.,
"Pathological breathing patterns after pneumococcal rhombencephalitis.",
Respir Care, vol. 59, issue 5, pp. e84-8, 2014 May.
Zheng, F., Put S., Bouwens L., Lahoutte T., Matthys P., Muyldermans S., De Baetselier P., Devoogdt N., Raes G., and Schoonooghe S.,
"Molecular imaging with macrophage CRIg-targeting nanobodies for early and preclinical diagnosis in a mouse model of rheumatoid arthritis.",
J Nucl Med, vol. 55, issue 5, pp. 824-9, 2014 May.
De Vos, J., Mathijs I., Xavier C., Massa S., Wernery U., Bouwens L., Lahoutte T., Muyldermans S., and Devoogdt N.,
"Specific targeting of atherosclerotic plaques in ApoE(-/-) mice using a new Camelid sdAb binding the vulnerable plaque marker LOX-1.",
Mol Imaging Biol, vol. 16, issue 5, pp. 690-8, 2014 Oct.
De Meyer, T., Muyldermans S., and Depicker A.,
"Nanobody-based products as research and diagnostic tools.",
Trends Biotechnol, vol. 32, issue 5, pp. 263-70, 2014 May.
Evazalipour, M., D'huyvetter M., Tehrani B. Soltani, Abolhassani M., Omidfar K., Abdoli S., Arezumand R., Morovvati H., Lahoutte T., Muyldermans S., et al.,
"Generation and characterization of nanobodies targeting PSMA for molecular imaging of prostate cancer.",
Contrast Media Mol Imaging, vol. 9, issue 3, pp. 211-20, 2014 May-Jun.
Massa, S., Xavier C., De Vos J., Caveliers V., Lahoutte T., Muyldermans S., and Devoogdt N.,
"Site-specific labeling of cysteine-tagged camelid single-domain antibody-fragments for use in molecular imaging.",
Bioconjug Chem, vol. 25, issue 5, pp. 979-88, 2014 May 21.
Cardoso, F. Miguel, Ibañez L. Itatí, Van den Hoecke S., De Baets S., Smet A., Roose K., Schepens B., Descamps F. J., Fiers W., Muyldermans S., et al.,
"Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge.",
J Virol, vol. 88, issue 15, pp. 8278-96, 2014 Aug.
D'huyvetter, M., Vincke C., Xavier C., Aerts A., Impens N., Baatout S., De Raeve H., Muyldermans S., Caveliers V., Devoogdt N., et al.,
"Targeted radionuclide therapy with A 177Lu-labeled anti-HER2 nanobody.",
Theranostics, vol. 4, issue 7, pp. 708-20, 2014.
Yardehnavi, N., Behdani M., Bagheri K. Pooshang, Mahmoodzadeh A., Khanahmad H., Shahbazzadeh D., Habibi-Anbouhi M., Ghassabeh G. Hassanzade, and Muyldermans S.,
"A camelid antibody candidate for development of a therapeutic agent against Hemiscorpius lepturus envenomation.",
FASEB J, 2014 Jun 2.
Li, H., Sun Y., Elseviers J., Muyldermans S., Liu S., and Wan Y.,
"A nanobody-based electrochemiluminescent immunosensor for sensitive detection of human procalcitonin.",
Analyst, vol. 139, issue 15, pp. 3718-21, 2014 Aug 7.
Pages
